No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes

CONCLUSION: Six months of treatment with 1.2 mg/day of liraglutide had no effect on the kinetics of HDL apoAI in patients with T2D. The lack of decrease in triglyceride content in HDL related to an only moderate decrease in triglyceridemia, probably greatly explains these results. Insufficient improvement of insulin sensitivity and adiponectinemia may also be implied.PMID:38653365 | DOI:10.1016/j.diabet.2024.101535
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Source Type: research